Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of María De Los Ángeles Estiarte Martínez
Introduction
María De Los Ángeles Estiarte Martínez is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications. His work focuses on innovative solutions for treating various diseases.
Latest Patents
María holds a patent for his invention titled "(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors." This invention relates to (hetero)aryl cyclopropylamine compounds, specifically the compounds of formula (I) as described and defined in the patent. The compounds are intended for use in therapy, including the treatment or prevention of cancer, neurological diseases or conditions, and viral infections. He has 1 patent to his name.
Career Highlights
María is currently associated with Oryzon Genomics S.A., a company known for its focus on innovative therapies. His work at Oryzon has positioned him as a key player in the development of new therapeutic agents. His research has the potential to impact the treatment landscape for several serious health conditions.
Collaborations
Throughout his career, María has collaborated with notable colleagues, including Alberto Ortega Muñoz and Matthew Colin Thor Fyfe. These collaborations have fostered a productive environment for innovation and research.
Conclusion
María De Los Ángeles Estiarte Martínez exemplifies the spirit of innovation in the field of medicinal chemistry. His contributions, particularly in the development of therapeutic compounds, highlight the importance of research in addressing critical health challenges.